Volume 18, Number 1—January 2012
Research
Assessing Prion Infectivity of Human Urine in Sporadic Creutzfeldt-Jakob Disease
Table 2
Carrier | Brain† dilution | Incubation time, d, mean ± SEM | Distribution | Prion titer, ID50/g tissue† |
---|---|---|---|---|
PBS‡ | 10−2 | 267 ± 14 | 5/5 | 7.2 × 106 |
100× concentrated and dialyzed normal human urine | 10−1 | 262 ± 4 | 5/5 | 3.3 × 105 |
10−2 | 281 ± 7 | 5/5 | ||
10−3 | 377 ± 35 | 6/6 | ||
10−4 | 311, 335 | 2/4 | ||
10−5 | >793 | 0/6 | ||
10−6 | >702 | 0/6 |
*sCJD, sporadic Creutzfeldt-Jakob disease; PBS, phosphate-buffered saline; ID50, 50% infectious dose.
†Brain tissue equivalent.
‡Titer was the same as calculated in Table 1.
1These authors contributed equally to this article.
Page created: December 22, 2011
Page updated: December 22, 2011
Page reviewed: December 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.